Winn RH (ed.), Youmans Neurological Surgery, Vol II chapter, 5th ed., New York: Saunders, 2004: 18391867
" ACHIEVE-3 gives us the first head-to-head comparison between two oral GLP-1 receptor agonist therapies in adults with type 2 diabetes, and the differences were clinically meaningful ," said Julio Rosenstock, MD, clinical professor of medicine at the University of Texas Southwestern Medical Center and the trial's lead investigator
Four separate bottles versus one complete system
Some studies say the medicine has some good effects, but you should always talk to your doctor for advice
Take 7.5 mL ( tablespoon) directly off the spoon or stir into water, juice, or smoothie no capsules to swallow, no chalky powders to mix
Rege, J